Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
In the first five months of this year, shipments of pharma products from Ireland to the United States were up nearly fourfold compared with the same period in 2024.
Simplified Text
Shipments of pharma products from Ireland to the United States were up nearly fourfold in the first five months of this year compared with 2024
Confidence Score
0.900
Claim Maker
The author
Context Type
News Article
Context Details
{
    "product": "Pharmaceutical products",
    "increase": "Nearly fourfold compared with 2024",
    "location": "Ireland",
    "timeframe": "First five months of 2025",
    "destination": "United States"
}
UUID
9fdae131-81c1-4d2c-b3ab-8320448f3219
Vector Index
✗ No vector
Created
September 11, 2025 at 8:58 PM (3 days ago)
Last Updated
September 11, 2025 at 8:58 PM (3 days ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://www.nytimes.com/2025/08/14/health/pharma-tariffs-ireland-taxes.html
https://www.nytimes.com/2025/08/14/health/pharma-tariffs-ireland-taxes.html

US drugmakers using Ireland for tax advantages face billions in tariffs on European medicines. Shifting production to the US increases costs. The situation highlights tax strategies and their impact.

Pharmaceutical Industry
International Trade
Taxation
Ireland
United States
Tariffs

Similar Claims (0)

Other claims identified as semantically similar to this one.

No similar claims found

This claim appears to be unique in the system.

Claim Management System - MVP